Patents Assigned to KYLIX, B.V.
  • Publication number: 20030158199
    Abstract: The present invention provides a method of inhibiting or moderating the kinase activity of tyrosine kinases comprising the administration of a compound represented by formula (1) said kinase in sufficient concentration to inhibit or moderate the enzyme activity of said kinase.
    Type: Application
    Filed: January 25, 2002
    Publication date: August 21, 2003
    Applicant: KYLIX, B.V.
    Inventors: Frank Stieber, Klaus Hellmuth, Herbert Waldmann, Ralph Mazitschek, Athanassios Giannis